Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response study in patients with Staphylococcus aureus infection or colonization
NL-OMON33490Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of human monoclonal antibodies against Staphylococcus aureus in Staphylococcus aureus infection and staphylococcal carrier state, sponsored by University Medical Center Groningen. Primary endpoint: Detectable IgA or IgG response against relevant staphylococcal antigens. Started Dec 2009; status: active, not recruiting.
02
Drugs
human monoclonal antibodies against Staphylococcus aureus
03
Conditions
Staphylococcus aureus infectionstaphylococcal carrier state
Beyond the preview
Go deeper on NL-OMON33490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33490.